Metagenomi, Inc. Common Stock (MGX) — Capital Reinvestment Ratio
Latest as of December 2022:
0.05x
Metagenomi, Inc. Common Stock (MGX) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($67.73 Million) in capital expenditures ($3.51 Million). See MGX cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$67.73 Million
USD
Capital Expenditures
$3.51 Million
USD
Data as of
Dec 2022
Most recent filing
Metagenomi, Inc. Common Stock Capital Reinvestment Ratio (2021–2022)
This chart tracks Metagenomi, Inc. Common Stock's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Metagenomi, Inc. Common Stock (2021–2022)
Year-by-year Capital Reinvestment Ratio for Metagenomi, Inc. Common Stock from 2021 to 2022. For live market cap and broader valuation context, see market cap of Metagenomi, Inc. Common Stock.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.47x | $29.72 Million | $13.98 Million | ▲ +292.9% |
| 2021 | 0.12x | $24.26 Million | $2.90 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow